STOCKS TELEGRAPH

Tag: VTVT

  • vTv Therapeutics (VTVT) Stock Skyrockets Post-Equity Completion

    vTv Therapeutics (VTVT) Stock Skyrockets Post-Equity Completion

    The shares of vTv Therapeutics Inc. (NASDAQ: VTVT) have experienced a notable surge this morning. Thia marked a significant increase of 153.26% in vTv stock to reach $21.02 per share, as verified in the current session. This uptrend in VTVT stock value coincides with the finalization of a financial operation.

    VTVT Therapeutics (VTVT) has completed a private offering with Samsara BioCapital, LLC (“Samsara”), a firm specializing in life sciences investments, along with the JDRF T1D Fund. On January 29, 2024, VTVT offered 464,377 shares of its common stock at a price of $11.81 per share, based on the 45-day Volume Weighted Average Price (VWAP).

    Furthermore, the private placement offering involved the purchase of warrants equivalent to 3,853,997 shares of common stock. A total of $51 million was generated from the PIPE. Also, in conjunction with the PIPE, vTv reduced the size of its Board of Directors from nine to seven members.

    Among the reconstituted board, three members will be appointed by the new investors, including Srinivas Akkaraju, MD, PhD, who serves as the Founder and Managing General Partner at Samsara. These strategic maneuvers aim to provide impetus to vTv’s pursuit, with the allocated funds intended to facilitate the commencement of the initial Phase 3 trial for its flagship product candidate, cadisegliatin, projected to begin in the middle of 2024.

    The company is poised to attract further investments of commendable quality as it readies itself for the inaugural Phase 3 trial of cadisegliatin. The resources amassed through the PIPE are anticipated to sustain vTv’s operations until the unveiling of topline data from the pivotal Phase 3 study of cadisegliatin, representing a significant milestone for the company.

    Having monitored vTv’s progress over an extended period, Samsara possesses an intimate understanding of cadisegliatin and harbors strong conviction regarding its potential to deliver substantial benefits to individuals grappling with T1D. Samsara pledges close collaboration with the VTVT Board and its team, offering guidance to propel the continued advancement of this highly promising initiative as it progresses towards Phase 3 development.

  • 32 Stocks Making Sharp Moves in Pre Market Session

    32 Stocks Making Sharp Moves in Pre Market Session

    Sundial Growers Inc. (SNDL) stock soared 1.72% to $0.5088 in the pre-market trading after declaring $50 million prepayment on senior secured non-revolving term credit facility. The most recent rating by CIBC, on August 17, 2020, is a Neutral.

    FuelCell Energy Inc. (FCEL) is up more than 2.09% at $8.31 in pre-market hours Wednesday December 16, 2020. The stock had jumped over 5.71% to $8.14 in the last trading session.

    BioCardia Inc. (NASDAQ: BCDA) shares are trading up 5.22% at $7.05 at the time of writing after reporting that it has entered into definitive agreements with investors for the purchase and sale of 1,789,474 shares of its common stock at a purchase price of $4.75 per share Company’s 52-week ranged between $1.91 to $6.95.

    Before the trading started on December 16, 2020, MicroVision Inc. (MVIS) is down -1.9% to reach $4.13. It has been trading in a 52-week range of $0.15 to $3.45.

    Apartment Investment and Management Company (AIV) tumbled over -6.75% at $4.7 in pre-market trading today following completion of separation of Apartment Income REIT Corp.

    Before the trading started on December 16, 2020, GeoVax Labs Inc. (GOVX) is down -7.86% to reach $3.4. It has been trading in a 52-week range of $2.30 to $60.00.

    Anchiano Therapeutics Ltd. (ANCN), a Biotechnology company, dropped about -7.99% at $2.65 in pre-market trading Wednesday after the company and and Chemomab Ltd. declared their entry into a definitive merger agreement.

    BEST Inc. (NYSE: BEST) shares are trading up 3.29% at $2.2 at the time of writing. Company’s 52-week ranged between $2.36 to $6.54. Analysts have a consensus price target of $3.50.

    Veru Inc. (VERU) stock moved down -7.5 percent to $8.63 in the pre-market trading. The company lately reported positive Phase 2 clinical trial results for Enobosarm.

    Northern Dynasty Minerals Ltd. (NAK) is up more than 3.67% at $0.325 in pre-market hours Wednesday December 16, 2020. The stock had dropped over -4.74% to $0.31 in the last trading session.

    Moderna Inc. (MRNA) stock plunged -3.33% to $142.32 in the pre-market trading. The company recently confirmed supply agreement with the Ministry of Health to supply Singapore with mRNA vaccine against COVID-19 (mRNA-1273). The most recent rating by Needham, on December 09, 2020, is a Hold.

    Before the trading started on December 16, 2020, Teligent Inc. (TLGT) is up 2.2% to reach $0.93. It has been trading in a 52-week range of $0.46 to $6.46.

    HEXO Corp. (HEXO), a Drug Manufacturers – Specialty & Generic company, rose about 2.75% at $1.12 in pre-market trading Wednesday. The firm recently revealed it first quarter fiscal 2021 financial results.

    Gevo Inc. (NASDAQ: GEVO) shares are trading up 4.74% at $1.99 at the time of writing. Company’s 52-week ranged between $0.46 to $2.91.

    Timber Pharmaceuticals Inc. (TMBR) stock moved down -0.97 percent to $1.02 in the pre-market trading after receiving notice of allowance from U.S. Patent and Trademark Office for Lead Asset TMB-001.

    Baidu Inc. (BIDU) is up more than 4.33% at $193.53 in pre-market hours Wednesday December 16, 2020. The stock had jumped over 13.83% to $185.50 in the last trading session.

    Aurora Cannabis Inc. (ACB) gained over 1.76% at $10.39 in pre-market trading Wednesday December 16, 2020 after provided a business update.

    Velodyne Lidar Inc. (VLDR) stock soared 3.91% to $20.2 in the pre-market trading after declaring a sales agreement for Alpha Prime sensors with May Mobility, a pioneer in autonomous vehicle (AV) technology. The most recent rating by Needham, on December 15, 2020, is a Buy.

    Before the trading started on December 16, 2020, Nikola Corporation (NKLA) is up 3.64% to reach $17.08. It has been trading in a 52-week range of $10.29 to $93.99.

    PG&E Corporation (NYSE: PCG) shares are trading up 2.87% at $12.55 at the time of writing after paying over $268 million in property taxes to 50 California counties. Company’s 52-week ranged between $6.25 to $18.34. Analysts have a consensus price target of $15.

    SELLAS Life Sciences Group Inc. (SLS) tumbled over -3.72% at $6.99 in pre-market trading today. The firm recently reported the pricing of $16.2 million registered direct offering.

    Nxt-ID Inc. (NASDAQ: NXTD) shares are trading down -1.66% at $0.4795 at the time of writing. Company’s 52-week ranged between $0.21 to $0.89.

    Qualigen Therapeutics Inc. (QLGN), a Biotechnology company, rose about 1.23% at $4.12 in pre-market trading Wednesday following its announcement of issuance of U.S. Patent for expanded applications of ALAN Anticancer Platform Technology.

    Concord Medical Services Holdings Limited (CCM) lost over -30.32% at $3.7 in pre-market trading Wednesday December 16, 2020.

    Aphria Inc. (APHA) grew over 11.45% at $9.05 in pre-market trading today following its declaration of definitive agreement with Tilray, Inc. (TLRY), to combine their businesses and create the world’s largest global cannabis company.

    Before the trading started on December 16, 2020, Hecla Mining Company (HL) is up 5.9% to reach $5.74. It has been trading in a 52-week range of $1.40 to $6.79.

    Twitter Inc. (TWTR), a Internet Content & Information company, rose about 3.1% at $54.46 in pre-market trading Wednesday after the declaration from the Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (AMZN), that Twitter (TWTR) has selected AWS to provide global cloud infrastructure to deliver Twitter timelines.

    Torchlight Energy Resources Inc. (TRCH) stock plunged -4.63% to $0.5332 in the pre-market trading. The most recent rating by ROTH Capital, on March 13, 2020, is a Neutral.

    Arvinas Inc. (ARVN) is up more than 1.41% at $75.3 in pre-market hours Wednesday December 16, 2020 after reporting the pricing of an underwritten public offering of 5,714,286 shares of its common stock at a price of $70.00 per share, before underwriting discounts and commissions.

    Cinedigm Corp. (CIDM) stock plunged -0.54% to $0.84 in the pre-market trading. The most recent rating by The Benchmark Company, on July 07, 2020, is a Speculative buy.

    PDL BioPharma Inc. (PDLI) grew over 6.59% at $2.75 in pre-market trading today. The company recently reported that it has entered into a Capital Provision Agreement with Epps Investments LLC.

    vTv Therapeutics Inc. (VTVT) is down more than -31.99% at $2.02 in pre-market hours Wednesday December 16, 2020 after revealing that the Phase 2 Elevage study of azeliragon in people with mild Alzheimer’s disease and type 2 diabetes did not meet its primary objective of demonstrating an improvement in cognition as assessed by the 14-item Alzheimer’s Disease Assessment Scale – Cognitive Subscale (ADAS-cog14) relative to placebo.

  • 31 stocks trending in pre-market

    31 stocks trending in pre-market

    NIO Limited (NIO) stock soared 2.95% to $42.19 in the pre-market trading following the pricing of offering of 68,000,000 American depositary shares. The most recent rating by Goldman, on December 01, 2020, is a Neutral. NIO Inc.

    Veru Inc. (NASDAQ: VERU) shares are trading up 7.17% at $10.39 at the time of writing after declaring positive Phase 2 clinical trial results for enobosarm, for the treatment of endocrine and chemotherapy resistant ER+/HER2- metastatic breast cancer, which was selected as a Spotlight Presentation at the 2020 San Antonio Breast Cancer Symposium. Company’s 52-week ranged between $2.10 to $7.86. Analysts have a consensus price target of $6.

    Occidental Petroleum Corporation (OXY) stock soared 2.45% to $19.64 in the pre-market trading. The most recent rating by MKM Partners, on December 07, 2020, is a Neutral.

    BioCardia Inc. (BCDA), a Biotechnology company, rose about 9.38% at $4.9 in pre-market trading Tuesday after reporting entry into definitive agreements with investors for the purchase and sale of 1,789,474 shares of its common stock at a purchase price of $4.75 per share in a registered direct offering priced at-the-market under Nasdaq rules.

    Genius Brands International Inc. (GNUS) gained over 15.85% at $2.12 in pre-market trading Tuesday December 15, 2020. The company recently revealed that it has secured a commitment to receive $100 million in cash on January 15, 2021 from New York-based Mudrick Capital Management as a result of a new first lien debt financing.

    Nikola Corporation (NKLA) is up more than 2.38% at $16.8 in pre-market hours Tuesday December 15, 2020. The stock had dropped over -6.87% to $16.41 in the last trading session.

    Virgin Galactic Holdings Inc. (SPCE) is up more than 2.83% at $27.22 in pre-market hours Tuesday December 15, 2020 following an update on test flight program. The stock had dropped over -17.38% to $26.47 in the last trading session.

    Before the trading started on December 15, 2020, Huntington Bancshares Incorporated (HBAN) is up 2.32% to reach $12.8 after reporting merger with TCF Financial Corporation to create top 10 U.S. regional bank. It has been trading in a 52-week range of $6.82 to $15.63.

    Plug Power Inc. (PLUG) stock soared 2.65% to $26.38 in the pre-market trading. The most recent rating by B. Riley Securities, on November 10, 2020, is a Buy.

    XPeng Inc. (NYSE: XPEV) shares are trading up 3.86% at $48.99 at the time of writing after its P7 super-long range sports sedan received car of the Year 2021 award in Xuanyuan Awards. Company’s 52-week ranged between $17.11 to $74.49. Analysts have a consensus price target of $58.

    AnPac Bio-Medical Science Co. Ltd. (ANPC), a Biotechnology company, dropped about -5.26% at $5.4 in pre-market trading Tuesday following the proclamation from the firm that it has made significant progress in detecting pre-cancer diseases.

    Yamana Gold Inc. (AUY) stock moved up 2.66 percent to $5.4 in the pre-market trading.

    Zynga Inc. (ZNGA) gained over 3.9% at $9.05 in pre-market trading Tuesday December 15, 2020 following the declaration of pricing of offering of $762 million of convertible senior notes.

    IZEA Worldwide Inc. (IZEA) is down more than -5.68% at $0.9243 in pre-market hours Tuesday December 15, 2020 after announcing that it has seen a surge of new customers in Q4 2020. The stock had jumped over 15.00% to $0.98 in the last trading session.

    Cameco Corporation (CCJ) grew over 3.16% at $13.7 in pre-market trading today.

    Before the trading started on December 15, 2020, HEXO Corp. (HEXO) is down -2.8% to reach $0.9817 after releasing its first quarter fiscal 2021 financial results. It has been trading in a 52-week range of $0.35 to $2.30.

    Nano Dimension Ltd. (NNDM) stock soared 1.8% to $6.77 in the pre-market trading. The most recent rating by Maxim Group, on October 21, 2016, is a Buy.

    Teligent Inc. (TLGT) tumbled over -3.53% at $0.78 in pre-market trading today.

    Synlogic Inc. (NASDAQ: SYBX) shares are trading down -5.51% at $2.4 at the time of writing following advancement of SYNB1891 to combination arm dosing with PD-L1 checkpoint inhibitor in the on-going phase 1 study for the treatment of solid tumors and lymphoma. Company’s 52-week ranged between $1.35 to $3.99.

    BioNTech SE (BNTX) stock soared 5.48% to $114.2 in the pre-market trading. The most recent rating by BofA Securities, on December 01, 2020, is a Neutral. Pfizer Inc. (PFE) and BioNTech SE (BNTX) recently declared additional data on neutralizing antibody and T cell responses from the Phase 1/2 trial with BNT162b2 conducted in Germany

    Torchlight Energy Resources Inc. (TRCH) tumbled over -12.14% at $0.543 in pre-market trading today.

    Seelos Therapeutics Inc. (SEEL) stock moved up 5.47 percent to $1.35 in the pre-market trading after revealing the sale of a $12.0 million senior secured convertible note and shares of Seelos common stock to investors.

    Bed Bath & Beyond Inc. (BBBY) gained over 4.35% at $19.69 in pre-market trading Tuesday December 15, 2020 following the declaration of definitive agreement to sell its remaining non-core banner Cost Plus World Market (CPWM) to Kingswood Capital Management, a Los Angeles-based private equity firm.

    Before the trading started on December 15, 2020, Aerpio Pharmaceuticals Inc. (ARPO) is down -3.33% to reach $1.16. It has been trading in a 52-week range of $0.42 to $2.31.

    Before the trading started on December 15, 2020, Energy Fuels Inc. (UUUU) is up 2.94% to reach $3.15 after reporting that it has entered into a three-year supply agreement with The Chemours Company (CC) to acquire a minimum of 2,500 tons per year of natural monazite sands. It has been trading in a 52-week range of $0.78 to $3.10.

    Uranium Energy Corp. (UEC) grew over 5.62% at $1.69 in pre-market trading today after filing fiscal 2021 Q1 quarterly report.

    MicroVision Inc. (MVIS), a Scientific & Technical Instruments company, rose about 5.43% at $3.3 in pre-market trading Tuesday.

    NovaBay Pharmaceuticals Inc. (NBY) is down more than -2.28% at $0.68 in pre-market hours Tuesday December 15, 2020 after reporting that its proprietary hypochlorous acid solution has received U.S. Environmental Protection Agency (EPA) approval for a kill claim against SARS-CoV-2, the virus that causes COVID-19. The stock had jumped over 0.86% to $0.70 in the last trading session.

    vTv Therapeutics Inc. (VTVT), a Biotechnology company, dropped about -10.44% at $2.66 in pre-market trading Tuesday after declaring a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.

    Socket Mobile Inc. (NASDAQ: SCKT) shares are trading down -15.38% at $2.42 at the time of writing. Company’s 52-week ranged between $0.76 to $4.50.

    ArcelorMittal (MT) grew over 4.3% at $22.08 in pre-market trading today after announcing investment agreement with Invitalia, an Italian state-owned company.

  • Pre-Market Cues: 30 Stocks Roaring for Change On December 14th

    Sonoma Pharmaceuticals Inc. (SNOA) stock plunged -7.53% to $8.1 in the pre-market trading after reporting partnership with Crown Laboratories to launch Microcyn® technology-based anti-itch over-the-counter products.

    Livent Corporation (NYSE: LTHM) shares are trading up 3.6% at $17.0 at the time of writing. Company’s 52-week ranged between $3.95 to $17.53. Analysts have a consensus price target of $16.50.

    Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) shares are trading down -5.45% at $2.95 at the time of writing after declaring offering of common stock. Company’s 52-week ranged between $1.03 to $5.31.

    NextDecade Corporation (NEXT) is down more than -7.25% at $3.2 in pre-market hours Monday December 14, 2020. The stock had jumped over 38.00% to $3.45 in the last trading session.

    FAT Brands Inc. (FAT) tumbled over -4.06% at $7.57 in pre-market trading today following the announcement from the company that it has entered into an agreement to combine with Fog Cutter Capital Group Inc. (FCCG), the Company’s controlling stockholder.

    Recro Pharma Inc. (REPH) stock soared 3.21% to $3.05 in the pre-market trading. The most recent rating by Stephens, on October 17, 2019, is an Overweight.

    Ampio Pharmaceuticals Inc. (AMPE) stock moved up 3.33 percent to $1.55 in the pre-market trading.

    ReTo Eco-Solutions Inc. (RETO), a Building Materials company, rose about 3.91% at $0.665 in pre-market trading Monday.

    Yiren Digital Ltd. (YRD) lost over -5.36% at $3.0 in pre-market trading Monday December 14, 2020. The firm recently announced that it has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug, Ampion™.

    Before the trading started on December 14, 2020, Sabre Corporation (SABR) is up 3.46% to reach $11.35. It has been trading in a 52-week range of $3.30 to $23.25.

    NantHealth Inc. (NH) is up more than 1.74% at $3.5 in pre-market hours Monday December 14, 2020. The company recently presented during a poster session at the San Antonio Breast Cancer Symposium (SABCS) new significant findings around the adoption of trastuzumab biosimilars in the treatment of HER2-positive breast cancer and the potential clinical and cost benefits of biosimilars. The stock had jumped over 22.42% to $3.44 in the last trading session.

    Torchlight Energy Resources Inc. (TRCH) stock soared 15.79% to $0.88 in the pre-market trading. The most recent rating by ROTH Capital, on March 13, 2020, is a Neutral.

    NIO Limited (NYSE: NIO) shares are trading down -6.38% at $39.3 at the time of writing following the announcement of pricing of offering of 68,000,000 American Depositary Shares. Company’s 52-week ranged between $2.11 to $57.20. Analysts have a consensus price target of $59.

    Lightbridge Corporation (LTBR) is down more than -2.4% at $3.66 in pre-market hours Monday December 14, 2020. The stock had jumped over 12.28% to $3.75 in the last trading session.

    Foresight Autonomous Holdings Ltd. (FRSX) stock moved up 2.31 percent to $1.77 in the pre-market trading after its affiliate, Rail Vision Ltd., has received an order from Knorr-Bremse Systeme für Schienenfahrzeuge GmbH, an affiliate of Knorr-Bremse AG (Frankfurt: KBX), for two samples of their light rail vehicle (LRV) system.

    Before the trading started on December 14, 2020, Hennessy Capital Acquisition Corp. IV (HCAC) is up 2.32% to reach $20.75. It has been trading in a 52-week range of $9.21 to $22.43.

    Inseego Corp. (INSG) stock soared 10.36% to $15.18 in the pre-market trading after reporting that the company is expanding its global footprint in Japan with the launch of its industry-leading 5G MiFi® M2000 mobile hotspot. The most recent rating by ROTH Capital, on August 06, 2020, is a Neutral.

    Mechel PAO (MTL) is down more than -3.66% at $1.84 in pre-market hours Monday December 14, 2020. The stock had jumped over 11.05% to $1.91 in the last trading session.

    JinkoSolar Holding Co. Ltd. (NYSE: JKS) shares are trading up 3.58% at $54.9 at the time of writing after declaring an update to 2020 annual general meeting agenda. Company’s 52-week ranged between $11.42 to $90.20. Analysts have a consensus price target of $55.

    Before the trading started on December 14, 2020, CureVac N.V. (CVAC) is up 6.7% to reach $125.99. It has been trading in a 52-week range of $36.15 to $151.80.

    Xeris Pharmaceuticals Inc. (XERS) grew over 2.84% at $4.7 in pre-market trading today after recent proclamation from company that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive Opinion for Ogluo™ (glucagon).

    Teligent Inc. (NASDAQ: TLGT) shares are trading up 85.54% at $1.17 at the time of writing. Company’s 52-week ranged between $0.46 to $6.46. Analysts have a consensus price target of $2.

    Marathon Patent Group Inc. (MARA) gained over 15.58% at $5.49 in pre-market trading Monday December 14, 2020. The firm recently announced a contract with Bitmain to purchase 10,000 Antminer S-19j Pro ASIC Miners.

    Sundial Growers Inc. (NASDAQ: SNDL) shares are trading up 4.64% at $0.53 at the time of writing after reporting that it has received approval to transfer the listing of its common shares to the Nasdaq Capital Market. Company’s 52-week ranged between $0.14 to $3.88.

    Neos Therapeutics Inc. (NEOS) tumbled over -5.61% at $0.6532 in pre-market trading today. The company and Aytu BioScience, Inc. (AYTU) recently declared that they have entered into a definitive merger agreement pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.

    Arbutus Biopharma Corporation (ABUS), a Biotechnology company, rose about 6.14% at $4.15 in pre-market trading Monday. The healthcare firm lately declared additional clinical data from an ongoing Phase 1a/1b clinical trial (AB-729-001) with AB-729, its proprietary GalNAc delivered RNAi compound.

    Greenwich LifeSciences Inc. (GLSI) lost over -16.07% at $47.0 in pre-market trading Monday December 14, 2020 following the publication of a second poster for the GP2 Phase III clinical trial design for recurring breast cancer at the San Antonio Breast Cancer Symposium (SABCS) in a virtual format.

    Veru Inc. (VERU) is up more than 19.12% at $7.57 in pre-market hours Monday December 14, 2020 following the company revealed positive Phase 2 clinical trial results for enobosarm, for the treatment of endocrine and chemotherapy resistant ER+/HER2- metastatic breast cancer. The stock had jumped over 6.45% to $6.36 in the last trading session.

    NanoVibronix Inc. (NAOV) stock plunged -6.36% to $1.03 in the pre-market trading after reporting that it has expanded and replaced its original distribution agreement with Ultra Pain Products, Inc..

    SELLAS Life Sciences Group Inc. (NASDAQ: SLS) shares are trading down -11.23% at $7.43 at the time of writing following the pricing of $16.2 million registered direct offering. Company’s 52-week ranged between $1.46 to $19.38.

  • Biotech Roundup &The delivery of the Pfizer’s vaccine to U.S. – starts Today

    Biotech Roundup &The delivery of the Pfizer’s vaccine to U.S. – starts Today

    This weekend, the U.S. government is packaging millions of doses of the coronavirus vaccine from Pfizer and BioNTech for distribution to places around the country, a mammoth logistics task in favor of what could be the most difficult immunization campaign in history.

    In delivering the vaccine, which is delicate and needs careful care, FedEx and UPS would play key roles. At the terminal, shipments can gain preferential entry. If a plane arrives to land with vaccinations, other passenger flights may have to loop around to wait for their chance.

    The arrival of the first vaccines comes as the virus continues to rage through the USA, with more than 207,000 new cases identified on Saturday by authorities. That took the number to more than 16 million, the most in the world by far. For the first time on Wednesday, more than 3,000 deaths were reported, and the country’s number is nearing 300,000.

    vTv Therapeutics Inc. (NASDAQ:VTVT) shares were trading up 41.55% at $3.10 at the time of writing on Friday. The firm on November 25, 2020 announced common stock purchase agreement for up to $47 million with Lincoln Park Capital.

    vTv Therapeutics Inc. (NASDAQ:VTVT) share price went from a low point around $1.44 to briefly over $4.23 in past 52 weeks, though shares have since pulled back to $3.10. VTVT market cap has remained high, hitting $161.79M at the time of writing, giving it price-to-sales ratio of more than 7350.

    If we look at the recent analyst rating VTVT, H.C. Wainwright initiated coverage on VTVT shares with a Buy rating.

    aTyr Pharma Inc. (LIFE) last closed at $4.64, in a 52-week range of $2.13 to $7.62. The company on November 13, 2020 released third quarter results and provided a corporate update.

    ADiTx Therapeutics Inc. (ADTX) stock soar by 3.77% to $2.48. The firm reported on December 8, 2020, that it will present at the 13th annual LD Micro main event conference on Tuesday, December 15, 2020 at 11:00 AM EST / 8:00 AM PST.

    9 Meters Biopharma Inc. (NASDAQ:NMTR) Shares headed falling, lower as much as -11.75%.

    Iterum Therapeutics plc (NASDAQ:ITRM) rose 11.72% after gaining more than $0.1 on Friday. The biotechnology firm declared on December 7,2020, filing of US patent application based on favorable written opinion of the International Search Authority.

    Vaxart Inc. (VXRT) last closed at $7.44, in a 52-week range of $0.28 to $17.49.

    Catabasis Pharmaceuticals Inc. (CATB) stock soar by 14.51% to $2.21. The most recent rating by Wedbush, on November 02, 2020, is at a Neutral.

    Advaxis Inc. (NASDAQ:ADXS) Shares headed rising, higher as much as 3.56%. The company on November 27, 2020 reported the closing of $9.2 million public offering. The most recent rating by Barclays, on August 03, 2016, is at an Overweight.

    Xeris Pharmaceuticals Inc. (NASDAQ:XERS) rose 11.74% after gaining more than $0.48 on Friday following an announcement from the company that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive Opinion for Ogluo™ (glucagon).

    Novavax Inc. (NVAX) last closed at $124.88, in a 52-week range of $3.65 to $189.40. The firm on December 9, 2020, declared the appointment of Margaret G. McGlynn, R. Ph. to its board as an independent director. Analysts have a consensus price target of $186.20.

    Corbus Pharmaceuticals Holdings Inc. (CRBP) stock soar by 1.52% to $1.34. The most recent rating by ROTH Capital, on September 08, 2020, is at a Neutral.

    Adaptimmune Therapeutics plc (NASDAQ:ADAP) Shares headed falling, lower as much as -1.23%. The most recent rating by Mizuho, on April 22, 2020, is at a Neutral.

    Novan Inc. (NASDAQ:NOVN) rose 1.10% after gaining more than $0.01 on Friday.

    Nabriva Therapeutics plc (NBRV) last closed at $2.44, in a 52-week range of $3.26 to $18.29. The company recently announced pricing of $15 million public offering.

    Salarius Pharmaceuticals Inc. (SLRX) stock drop by -31.34% to $0.92 after declaring that it has entered into agreements with several institutional and accredited investors to exercise of warrants for $3.5 million of gross proceeds to be used for ongoing development of Seclidemstat. The most recent rating by Ladenburg Thalmann, on April 27, 2020, is at a Buy.